Global Teriflunomide Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Teriflunomide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Teriflunomide is an oral immunomodulatory agent with anti-inflammatory properties that inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in de novo pyrimidine synthesis, thereby reducing the number of activated lymphocytes in the central nervous system and mitigating autoimmune-mediated inflammation. It is primarily indicated for the treatment of relapsing multiple sclerosis, helping to slow disease progression and reduce relapse frequency, making it an important therapeutic option in clinical management of multiple sclerosis patients. In 2024, the global sales volume of teriflunomide reached 3.02 million units, with an average price of 850 USD per unit.The global teriflunomide market is experiencing steady growth, with North America, Europe, and the Asia-Pacific region accounting for the majority of multiple sclerosis (MS) patients worldwide. Rising early diagnosis rates and increased awareness of long-term disease management are driving expanding market demand. The originator, Sanofi, maintains strong brand recognition and an established global distribution network, while domestic and international generic manufacturers have obtained approvals, promoting price competition, improving accessibility, and optimizing drug utilization within healthcare systems. Innovations in formulation and technology are further stimulating growth, including oral dosage form optimization, adherence-enhancing strategies, and chronic disease management support services. Future trends are expected to be influenced by changes in reimbursement policies, inclusion in rare disease lists, pricing negotiations, and global supply chain strategies. The expansion of multi-source supply, personalized treatment approaches, and patient-centric care models will continue to increase market size, improve accessibility, and diversify the competitive landscape.The upstream raw materials for teriflunomide primarily include chemical intermediates and key reagents used in the synthesis of the active pharmaceutical ingredient, as well as excipients for formulation. The synthesis of the API relies on high-purity precursors of dihydroorotate dehydrogenase inhibitors and specific organic intermediates, typically supplied by large chemical manufacturers and CDMOs, which are responsible for ensuring material purity, batch-to-batch consistency, and supply stability. Excipients such as disintegrants, lubricants, and fillers must also meet GMP standards to ensure uniformity, stability, and safety of the final tablet formulation, making reliability and diversification of the raw material supply chain critical.
The global Teriflunomide market size was estimated at USD 2568.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Teriflunomide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Teriflunomide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Teriflunomide market.
Global Teriflunomide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
Cisen Pharmaceutical
Nanjing Healthnice Pharmaceutical
CGeneTech (Suzhou, China)
Mylan
Zydus
Accord Healthcare
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
Camber Pharmaceuticals
Alembic
Apotex
Aurobindo Pharma
SOLA Pharmaceuticals
Sandoz
Market Segmentation (by Type)
7mg per Tablet
14mg per Tablet
Market Segmentation (by Application)
Hospital and Clinic
Retail Pharmacies
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Teriflunomide Market
Overview of the regional outlook of the Teriflunomide Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Teriflunomide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Teriflunomide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Teriflunomide market size was estimated at USD 2568.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Teriflunomide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Teriflunomide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Teriflunomide market.
Global Teriflunomide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
Cisen Pharmaceutical
Nanjing Healthnice Pharmaceutical
CGeneTech (Suzhou, China)
Mylan
Zydus
Accord Healthcare
Dr. Reddy's Laboratories
Glenmark Pharmaceuticals
Teva
Camber Pharmaceuticals
Alembic
Apotex
Aurobindo Pharma
SOLA Pharmaceuticals
Sandoz
Market Segmentation (by Type)
7mg per Tablet
14mg per Tablet
Market Segmentation (by Application)
Hospital and Clinic
Retail Pharmacies
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Teriflunomide Market
Overview of the regional outlook of the Teriflunomide Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Teriflunomide Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Teriflunomide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Teriflunomide
1.2 Key Market Segments
1.2.1 Teriflunomide Segment by Type
1.2.2 Teriflunomide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TERIFLUNOMIDE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Teriflunomide Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Teriflunomide Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TERIFLUNOMIDE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Teriflunomide Product Life Cycle
3.3 Global Teriflunomide Sales by Manufacturers (2020-2025)
3.4 Global Teriflunomide Revenue Market Share by Manufacturers (2020-2025)
3.5 Teriflunomide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Teriflunomide Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Teriflunomide Market Competitive Situation and Trends
3.8.1 Teriflunomide Market Concentration Rate
3.8.2 Global 5 and 10 Largest Teriflunomide Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TERIFLUNOMIDE INDUSTRY CHAIN ANALYSIS
4.1 Teriflunomide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TERIFLUNOMIDE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Teriflunomide Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Teriflunomide Market
5.7 ESG Ratings of Leading Companies
6 TERIFLUNOMIDE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Teriflunomide Sales Market Share by Type (2020-2025)
6.3 Global Teriflunomide Market Size by Type (2020-2025)
6.4 Global Teriflunomide Price by Type (2020-2025)
7 TERIFLUNOMIDE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Teriflunomide Market Sales by Application (2020-2025)
7.3 Global Teriflunomide Market Size (M USD) by Application (2020-2025)
7.4 Global Teriflunomide Sales Growth Rate by Application (2020-2025)
8 TERIFLUNOMIDE MARKET SALES BY REGION
8.1 Global Teriflunomide Sales by Region
8.1.1 Global Teriflunomide Sales by Region
8.1.2 Global Teriflunomide Sales Market Share by Region
8.2 Global Teriflunomide Market Size by Region
8.2.1 Global Teriflunomide Market Size by Region
8.2.2 Global Teriflunomide Market Size by Region
8.3 North America
8.3.1 North America Teriflunomide Sales by Country
8.3.2 North America Teriflunomide Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Teriflunomide Sales by Country
8.4.2 Europe Teriflunomide Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Teriflunomide Sales by Region
8.5.2 Asia Pacific Teriflunomide Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Teriflunomide Sales by Country
8.6.2 South America Teriflunomide Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Teriflunomide Sales by Region
8.7.2 Middle East and Africa Teriflunomide Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TERIFLUNOMIDE MARKET PRODUCTION BY REGION
9.1 Global Production of Teriflunomide by Region(2020-2025)
9.2 Global Teriflunomide Revenue Market Share by Region (2020-2025)
9.3 Global Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Teriflunomide Production
9.4.1 North America Teriflunomide Production Growth Rate (2020-2025)
9.4.2 North America Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Teriflunomide Production
9.5.1 Europe Teriflunomide Production Growth Rate (2020-2025)
9.5.2 Europe Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Teriflunomide Production (2020-2025)
9.6.1 Japan Teriflunomide Production Growth Rate (2020-2025)
9.6.2 Japan Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Teriflunomide Production (2020-2025)
9.7.1 China Teriflunomide Production Growth Rate (2020-2025)
9.7.2 China Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Teriflunomide Product Overview
10.1.3 Sanofi Teriflunomide Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Cisen Pharmaceutical
10.2.1 Cisen Pharmaceutical Basic Information
10.2.2 Cisen Pharmaceutical Teriflunomide Product Overview
10.2.3 Cisen Pharmaceutical Teriflunomide Product Market Performance
10.2.4 Cisen Pharmaceutical Business Overview
10.2.5 Cisen Pharmaceutical SWOT Analysis
10.2.6 Cisen Pharmaceutical Recent Developments
10.3 Nanjing Healthnice Pharmaceutical
10.3.1 Nanjing Healthnice Pharmaceutical Basic Information
10.3.2 Nanjing Healthnice Pharmaceutical Teriflunomide Product Overview
10.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Product Market Performance
10.3.4 Nanjing Healthnice Pharmaceutical Business Overview
10.3.5 Nanjing Healthnice Pharmaceutical SWOT Analysis
10.3.6 Nanjing Healthnice Pharmaceutical Recent Developments
10.4 CGeneTech (Suzhou, China)
10.4.1 CGeneTech (Suzhou, China) Basic Information
10.4.2 CGeneTech (Suzhou, China) Teriflunomide Product Overview
10.4.3 CGeneTech (Suzhou, China) Teriflunomide Product Market Performance
10.4.4 CGeneTech (Suzhou, China) Business Overview
10.4.5 CGeneTech (Suzhou, China) Recent Developments
10.5 Mylan
10.5.1 Mylan Basic Information
10.5.2 Mylan Teriflunomide Product Overview
10.5.3 Mylan Teriflunomide Product Market Performance
10.5.4 Mylan Business Overview
10.5.5 Mylan Recent Developments
10.6 Zydus
10.6.1 Zydus Basic Information
10.6.2 Zydus Teriflunomide Product Overview
10.6.3 Zydus Teriflunomide Product Market Performance
10.6.4 Zydus Business Overview
10.6.5 Zydus Recent Developments
10.7 Accord Healthcare
10.7.1 Accord Healthcare Basic Information
10.7.2 Accord Healthcare Teriflunomide Product Overview
10.7.3 Accord Healthcare Teriflunomide Product Market Performance
10.7.4 Accord Healthcare Business Overview
10.7.5 Accord Healthcare Recent Developments
10.8 Dr. Reddy's Laboratories
10.8.1 Dr. Reddy's Laboratories Basic Information
10.8.2 Dr. Reddy's Laboratories Teriflunomide Product Overview
10.8.3 Dr. Reddy's Laboratories Teriflunomide Product Market Performance
10.8.4 Dr. Reddy's Laboratories Business Overview
10.8.5 Dr. Reddy's Laboratories Recent Developments
10.9 Glenmark Pharmaceuticals
10.9.1 Glenmark Pharmaceuticals Basic Information
10.9.2 Glenmark Pharmaceuticals Teriflunomide Product Overview
10.9.3 Glenmark Pharmaceuticals Teriflunomide Product Market Performance
10.9.4 Glenmark Pharmaceuticals Business Overview
10.9.5 Glenmark Pharmaceuticals Recent Developments
10.10 Teva
10.10.1 Teva Basic Information
10.10.2 Teva Teriflunomide Product Overview
10.10.3 Teva Teriflunomide Product Market Performance
10.10.4 Teva Business Overview
10.10.5 Teva Recent Developments
10.11 Camber Pharmaceuticals
10.11.1 Camber Pharmaceuticals Basic Information
10.11.2 Camber Pharmaceuticals Teriflunomide Product Overview
10.11.3 Camber Pharmaceuticals Teriflunomide Product Market Performance
10.11.4 Camber Pharmaceuticals Business Overview
10.11.5 Camber Pharmaceuticals Recent Developments
10.12 Alembic
10.12.1 Alembic Basic Information
10.12.2 Alembic Teriflunomide Product Overview
10.12.3 Alembic Teriflunomide Product Market Performance
10.12.4 Alembic Business Overview
10.12.5 Alembic Recent Developments
10.13 Apotex
10.13.1 Apotex Basic Information
10.13.2 Apotex Teriflunomide Product Overview
10.13.3 Apotex Teriflunomide Product Market Performance
10.13.4 Apotex Business Overview
10.13.5 Apotex Recent Developments
10.14 Aurobindo Pharma
10.14.1 Aurobindo Pharma Basic Information
10.14.2 Aurobindo Pharma Teriflunomide Product Overview
10.14.3 Aurobindo Pharma Teriflunomide Product Market Performance
10.14.4 Aurobindo Pharma Business Overview
10.14.5 Aurobindo Pharma Recent Developments
10.15 SOLA Pharmaceuticals
10.15.1 SOLA Pharmaceuticals Basic Information
10.15.2 SOLA Pharmaceuticals Teriflunomide Product Overview
10.15.3 SOLA Pharmaceuticals Teriflunomide Product Market Performance
10.15.4 SOLA Pharmaceuticals Business Overview
10.15.5 SOLA Pharmaceuticals Recent Developments
10.16 Sandoz
10.16.1 Sandoz Basic Information
10.16.2 Sandoz Teriflunomide Product Overview
10.16.3 Sandoz Teriflunomide Product Market Performance
10.16.4 Sandoz Business Overview
10.16.5 Sandoz Recent Developments
11 TERIFLUNOMIDE MARKET FORECAST BY REGION
11.1 Global Teriflunomide Market Size Forecast
11.2 Global Teriflunomide Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Teriflunomide Market Size Forecast by Country
11.2.3 Asia Pacific Teriflunomide Market Size Forecast by Region
11.2.4 South America Teriflunomide Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Teriflunomide by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Teriflunomide Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Teriflunomide by Type (2026-2035)
12.1.2 Global Teriflunomide Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Teriflunomide by Type (2026-2035)
12.2 Global Teriflunomide Market Forecast by Application (2026-2035)
12.2.1 Global Teriflunomide Sales (K MT) Forecast by Application
12.2.2 Global Teriflunomide Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Teriflunomide
1.2 Key Market Segments
1.2.1 Teriflunomide Segment by Type
1.2.2 Teriflunomide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TERIFLUNOMIDE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Teriflunomide Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Teriflunomide Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TERIFLUNOMIDE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Teriflunomide Product Life Cycle
3.3 Global Teriflunomide Sales by Manufacturers (2020-2025)
3.4 Global Teriflunomide Revenue Market Share by Manufacturers (2020-2025)
3.5 Teriflunomide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Teriflunomide Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Teriflunomide Market Competitive Situation and Trends
3.8.1 Teriflunomide Market Concentration Rate
3.8.2 Global 5 and 10 Largest Teriflunomide Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 TERIFLUNOMIDE INDUSTRY CHAIN ANALYSIS
4.1 Teriflunomide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TERIFLUNOMIDE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Teriflunomide Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Teriflunomide Market
5.7 ESG Ratings of Leading Companies
6 TERIFLUNOMIDE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Teriflunomide Sales Market Share by Type (2020-2025)
6.3 Global Teriflunomide Market Size by Type (2020-2025)
6.4 Global Teriflunomide Price by Type (2020-2025)
7 TERIFLUNOMIDE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Teriflunomide Market Sales by Application (2020-2025)
7.3 Global Teriflunomide Market Size (M USD) by Application (2020-2025)
7.4 Global Teriflunomide Sales Growth Rate by Application (2020-2025)
8 TERIFLUNOMIDE MARKET SALES BY REGION
8.1 Global Teriflunomide Sales by Region
8.1.1 Global Teriflunomide Sales by Region
8.1.2 Global Teriflunomide Sales Market Share by Region
8.2 Global Teriflunomide Market Size by Region
8.2.1 Global Teriflunomide Market Size by Region
8.2.2 Global Teriflunomide Market Size by Region
8.3 North America
8.3.1 North America Teriflunomide Sales by Country
8.3.2 North America Teriflunomide Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Teriflunomide Sales by Country
8.4.2 Europe Teriflunomide Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Teriflunomide Sales by Region
8.5.2 Asia Pacific Teriflunomide Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Teriflunomide Sales by Country
8.6.2 South America Teriflunomide Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Teriflunomide Sales by Region
8.7.2 Middle East and Africa Teriflunomide Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 TERIFLUNOMIDE MARKET PRODUCTION BY REGION
9.1 Global Production of Teriflunomide by Region(2020-2025)
9.2 Global Teriflunomide Revenue Market Share by Region (2020-2025)
9.3 Global Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Teriflunomide Production
9.4.1 North America Teriflunomide Production Growth Rate (2020-2025)
9.4.2 North America Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Teriflunomide Production
9.5.1 Europe Teriflunomide Production Growth Rate (2020-2025)
9.5.2 Europe Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Teriflunomide Production (2020-2025)
9.6.1 Japan Teriflunomide Production Growth Rate (2020-2025)
9.6.2 Japan Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Teriflunomide Production (2020-2025)
9.7.1 China Teriflunomide Production Growth Rate (2020-2025)
9.7.2 China Teriflunomide Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Teriflunomide Product Overview
10.1.3 Sanofi Teriflunomide Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Cisen Pharmaceutical
10.2.1 Cisen Pharmaceutical Basic Information
10.2.2 Cisen Pharmaceutical Teriflunomide Product Overview
10.2.3 Cisen Pharmaceutical Teriflunomide Product Market Performance
10.2.4 Cisen Pharmaceutical Business Overview
10.2.5 Cisen Pharmaceutical SWOT Analysis
10.2.6 Cisen Pharmaceutical Recent Developments
10.3 Nanjing Healthnice Pharmaceutical
10.3.1 Nanjing Healthnice Pharmaceutical Basic Information
10.3.2 Nanjing Healthnice Pharmaceutical Teriflunomide Product Overview
10.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Product Market Performance
10.3.4 Nanjing Healthnice Pharmaceutical Business Overview
10.3.5 Nanjing Healthnice Pharmaceutical SWOT Analysis
10.3.6 Nanjing Healthnice Pharmaceutical Recent Developments
10.4 CGeneTech (Suzhou, China)
10.4.1 CGeneTech (Suzhou, China) Basic Information
10.4.2 CGeneTech (Suzhou, China) Teriflunomide Product Overview
10.4.3 CGeneTech (Suzhou, China) Teriflunomide Product Market Performance
10.4.4 CGeneTech (Suzhou, China) Business Overview
10.4.5 CGeneTech (Suzhou, China) Recent Developments
10.5 Mylan
10.5.1 Mylan Basic Information
10.5.2 Mylan Teriflunomide Product Overview
10.5.3 Mylan Teriflunomide Product Market Performance
10.5.4 Mylan Business Overview
10.5.5 Mylan Recent Developments
10.6 Zydus
10.6.1 Zydus Basic Information
10.6.2 Zydus Teriflunomide Product Overview
10.6.3 Zydus Teriflunomide Product Market Performance
10.6.4 Zydus Business Overview
10.6.5 Zydus Recent Developments
10.7 Accord Healthcare
10.7.1 Accord Healthcare Basic Information
10.7.2 Accord Healthcare Teriflunomide Product Overview
10.7.3 Accord Healthcare Teriflunomide Product Market Performance
10.7.4 Accord Healthcare Business Overview
10.7.5 Accord Healthcare Recent Developments
10.8 Dr. Reddy's Laboratories
10.8.1 Dr. Reddy's Laboratories Basic Information
10.8.2 Dr. Reddy's Laboratories Teriflunomide Product Overview
10.8.3 Dr. Reddy's Laboratories Teriflunomide Product Market Performance
10.8.4 Dr. Reddy's Laboratories Business Overview
10.8.5 Dr. Reddy's Laboratories Recent Developments
10.9 Glenmark Pharmaceuticals
10.9.1 Glenmark Pharmaceuticals Basic Information
10.9.2 Glenmark Pharmaceuticals Teriflunomide Product Overview
10.9.3 Glenmark Pharmaceuticals Teriflunomide Product Market Performance
10.9.4 Glenmark Pharmaceuticals Business Overview
10.9.5 Glenmark Pharmaceuticals Recent Developments
10.10 Teva
10.10.1 Teva Basic Information
10.10.2 Teva Teriflunomide Product Overview
10.10.3 Teva Teriflunomide Product Market Performance
10.10.4 Teva Business Overview
10.10.5 Teva Recent Developments
10.11 Camber Pharmaceuticals
10.11.1 Camber Pharmaceuticals Basic Information
10.11.2 Camber Pharmaceuticals Teriflunomide Product Overview
10.11.3 Camber Pharmaceuticals Teriflunomide Product Market Performance
10.11.4 Camber Pharmaceuticals Business Overview
10.11.5 Camber Pharmaceuticals Recent Developments
10.12 Alembic
10.12.1 Alembic Basic Information
10.12.2 Alembic Teriflunomide Product Overview
10.12.3 Alembic Teriflunomide Product Market Performance
10.12.4 Alembic Business Overview
10.12.5 Alembic Recent Developments
10.13 Apotex
10.13.1 Apotex Basic Information
10.13.2 Apotex Teriflunomide Product Overview
10.13.3 Apotex Teriflunomide Product Market Performance
10.13.4 Apotex Business Overview
10.13.5 Apotex Recent Developments
10.14 Aurobindo Pharma
10.14.1 Aurobindo Pharma Basic Information
10.14.2 Aurobindo Pharma Teriflunomide Product Overview
10.14.3 Aurobindo Pharma Teriflunomide Product Market Performance
10.14.4 Aurobindo Pharma Business Overview
10.14.5 Aurobindo Pharma Recent Developments
10.15 SOLA Pharmaceuticals
10.15.1 SOLA Pharmaceuticals Basic Information
10.15.2 SOLA Pharmaceuticals Teriflunomide Product Overview
10.15.3 SOLA Pharmaceuticals Teriflunomide Product Market Performance
10.15.4 SOLA Pharmaceuticals Business Overview
10.15.5 SOLA Pharmaceuticals Recent Developments
10.16 Sandoz
10.16.1 Sandoz Basic Information
10.16.2 Sandoz Teriflunomide Product Overview
10.16.3 Sandoz Teriflunomide Product Market Performance
10.16.4 Sandoz Business Overview
10.16.5 Sandoz Recent Developments
11 TERIFLUNOMIDE MARKET FORECAST BY REGION
11.1 Global Teriflunomide Market Size Forecast
11.2 Global Teriflunomide Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Teriflunomide Market Size Forecast by Country
11.2.3 Asia Pacific Teriflunomide Market Size Forecast by Region
11.2.4 South America Teriflunomide Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Teriflunomide by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Teriflunomide Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Teriflunomide by Type (2026-2035)
12.1.2 Global Teriflunomide Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Teriflunomide by Type (2026-2035)
12.2 Global Teriflunomide Market Forecast by Application (2026-2035)
12.2.1 Global Teriflunomide Sales (K MT) Forecast by Application
12.2.2 Global Teriflunomide Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Teriflunomide Market Size by Type (M USD)
Table 4. Global Teriflunomide Market Size by Application
Table 5. Teriflunomide Market Size Comparison by Region (M USD)
Table 6. Global Teriflunomide Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Teriflunomide Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Teriflunomide Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Teriflunomide Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teriflunomide as of 2025)
Table 11. Global Market Teriflunomide Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Teriflunomide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Teriflunomide Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Teriflunomide Sales by Type (K MT)
Table 27. Global Teriflunomide Market Size by Type (M USD)
Table 28. Global Teriflunomide Sales (K MT) by Type (2020-2025)
Table 29. Global Teriflunomide Sales Market Share by Type (2020-2025)
Table 30. Global Teriflunomide Market Size (M USD) by Type (2020-2025)
Table 31. Global Teriflunomide Market Share by Type (2020-2025)
Table 32. Global Teriflunomide Price (USD/KG) by Type (2020-2025)
Table 33. Global Teriflunomide Sales (K MT) by Application
Table 34. Global Teriflunomide Market Size by Application
Table 35. Global Teriflunomide Sales by Application (2020-2025) & (K MT)
Table 36. Global Teriflunomide Sales Market Share by Application (2020-2025)
Table 37. Global Teriflunomide Market Size by Application (2020-2025) & (M USD)
Table 38. Global Teriflunomide Market Share by Application (2020-2025)
Table 39. Global Teriflunomide Sales Growth Rate by Application (2020-2025)
Table 40. Global Teriflunomide Sales by Region (2020-2025) & (K MT)
Table 41. Global Teriflunomide Sales Market Share by Region (2020-2025)
Table 42. Global Teriflunomide Market Size by Region (2020-2025) & (M USD)
Table 43. Global Teriflunomide Market Size by Region (2020-2025)
Table 44. North America Teriflunomide Sales by Country (2020-2025) & (K MT)
Table 45. North America Teriflunomide Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Teriflunomide Sales by Country (2020-2025) & (K MT)
Table 47. Europe Teriflunomide Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Teriflunomide Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Teriflunomide Market Size by Region (2020-2025) & (M USD)
Table 50. South America Teriflunomide Sales by Country (2020-2025) & (K MT)
Table 51. South America Teriflunomide Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Teriflunomide Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Teriflunomide Market Size by Region (2020-2025) & (M USD)
Table 54. Global Teriflunomide Production (K MT) by Region(2020-2025)
Table 55. Global Teriflunomide Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Teriflunomide Revenue Market Share by Region (2020-2025)
Table 57. Global Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Teriflunomide Product Overview
Table 64. Sanofi Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Cisen Pharmaceutical Basic Information
Table 69. Cisen Pharmaceutical Teriflunomide Product Overview
Table 70. Cisen Pharmaceutical Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Cisen Pharmaceutical Business Overview
Table 72. Cisen Pharmaceutical SWOT Analysis
Table 73. Cisen Pharmaceutical Recent Developments
Table 74. Nanjing Healthnice Pharmaceutical Basic Information
Table 75. Nanjing Healthnice Pharmaceutical Teriflunomide Product Overview
Table 76. Nanjing Healthnice Pharmaceutical Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Nanjing Healthnice Pharmaceutical Business Overview
Table 78. Nanjing Healthnice Pharmaceutical SWOT Analysis
Table 79. Nanjing Healthnice Pharmaceutical Recent Developments
Table 80. CGeneTech (Suzhou, China) Basic Information
Table 81. CGeneTech (Suzhou, China) Teriflunomide Product Overview
Table 82. CGeneTech (Suzhou, China) Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CGeneTech (Suzhou, China) Business Overview
Table 84. CGeneTech (Suzhou, China) Recent Developments
Table 85. Mylan Basic Information
Table 86. Mylan Teriflunomide Product Overview
Table 87. Mylan Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Mylan Business Overview
Table 89. Mylan Recent Developments
Table 90. Zydus Basic Information
Table 91. Zydus Teriflunomide Product Overview
Table 92. Zydus Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zydus Business Overview
Table 94. Zydus Recent Developments
Table 95. Accord Healthcare Basic Information
Table 96. Accord Healthcare Teriflunomide Product Overview
Table 97. Accord Healthcare Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Accord Healthcare Business Overview
Table 99. Accord Healthcare Recent Developments
Table 100. Dr. Reddy's Laboratories Basic Information
Table 101. Dr. Reddy's Laboratories Teriflunomide Product Overview
Table 102. Dr. Reddy's Laboratories Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Dr. Reddy's Laboratories Business Overview
Table 104. Dr. Reddy's Laboratories Recent Developments
Table 105. Glenmark Pharmaceuticals Basic Information
Table 106. Glenmark Pharmaceuticals Teriflunomide Product Overview
Table 107. Glenmark Pharmaceuticals Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Glenmark Pharmaceuticals Business Overview
Table 109. Glenmark Pharmaceuticals Recent Developments
Table 110. Teva Basic Information
Table 111. Teva Teriflunomide Product Overview
Table 112. Teva Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Teva Business Overview
Table 114. Teva Recent Developments
Table 115. Camber Pharmaceuticals Basic Information
Table 116. Camber Pharmaceuticals Teriflunomide Product Overview
Table 117. Camber Pharmaceuticals Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Camber Pharmaceuticals Business Overview
Table 119. Camber Pharmaceuticals Recent Developments
Table 120. Alembic Basic Information
Table 121. Alembic Teriflunomide Product Overview
Table 122. Alembic Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Alembic Business Overview
Table 124. Alembic Recent Developments
Table 125. Apotex Basic Information
Table 126. Apotex Teriflunomide Product Overview
Table 127. Apotex Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Apotex Business Overview
Table 129. Apotex Recent Developments
Table 130. Aurobindo Pharma Basic Information
Table 131. Aurobindo Pharma Teriflunomide Product Overview
Table 132. Aurobindo Pharma Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Aurobindo Pharma Business Overview
Table 134. Aurobindo Pharma Recent Developments
Table 135. SOLA Pharmaceuticals Basic Information
Table 136. SOLA Pharmaceuticals Teriflunomide Product Overview
Table 137. SOLA Pharmaceuticals Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. SOLA Pharmaceuticals Business Overview
Table 139. SOLA Pharmaceuticals Recent Developments
Table 140. Sandoz Basic Information
Table 141. Sandoz Teriflunomide Product Overview
Table 142. Sandoz Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Sandoz Business Overview
Table 144. Sandoz Recent Developments
Table 145. Global Teriflunomide Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Teriflunomide Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Teriflunomide Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Teriflunomide Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Teriflunomide Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Teriflunomide Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Teriflunomide Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Teriflunomide Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Teriflunomide Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Teriflunomide Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Teriflunomide Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Teriflunomide Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Teriflunomide Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Teriflunomide Market Size by Type (M USD)
Table 4. Global Teriflunomide Market Size by Application
Table 5. Teriflunomide Market Size Comparison by Region (M USD)
Table 6. Global Teriflunomide Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Teriflunomide Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Teriflunomide Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Teriflunomide Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teriflunomide as of 2025)
Table 11. Global Market Teriflunomide Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Teriflunomide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Teriflunomide Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Teriflunomide Sales by Type (K MT)
Table 27. Global Teriflunomide Market Size by Type (M USD)
Table 28. Global Teriflunomide Sales (K MT) by Type (2020-2025)
Table 29. Global Teriflunomide Sales Market Share by Type (2020-2025)
Table 30. Global Teriflunomide Market Size (M USD) by Type (2020-2025)
Table 31. Global Teriflunomide Market Share by Type (2020-2025)
Table 32. Global Teriflunomide Price (USD/KG) by Type (2020-2025)
Table 33. Global Teriflunomide Sales (K MT) by Application
Table 34. Global Teriflunomide Market Size by Application
Table 35. Global Teriflunomide Sales by Application (2020-2025) & (K MT)
Table 36. Global Teriflunomide Sales Market Share by Application (2020-2025)
Table 37. Global Teriflunomide Market Size by Application (2020-2025) & (M USD)
Table 38. Global Teriflunomide Market Share by Application (2020-2025)
Table 39. Global Teriflunomide Sales Growth Rate by Application (2020-2025)
Table 40. Global Teriflunomide Sales by Region (2020-2025) & (K MT)
Table 41. Global Teriflunomide Sales Market Share by Region (2020-2025)
Table 42. Global Teriflunomide Market Size by Region (2020-2025) & (M USD)
Table 43. Global Teriflunomide Market Size by Region (2020-2025)
Table 44. North America Teriflunomide Sales by Country (2020-2025) & (K MT)
Table 45. North America Teriflunomide Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Teriflunomide Sales by Country (2020-2025) & (K MT)
Table 47. Europe Teriflunomide Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Teriflunomide Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Teriflunomide Market Size by Region (2020-2025) & (M USD)
Table 50. South America Teriflunomide Sales by Country (2020-2025) & (K MT)
Table 51. South America Teriflunomide Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Teriflunomide Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Teriflunomide Market Size by Region (2020-2025) & (M USD)
Table 54. Global Teriflunomide Production (K MT) by Region(2020-2025)
Table 55. Global Teriflunomide Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Teriflunomide Revenue Market Share by Region (2020-2025)
Table 57. Global Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Teriflunomide Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Teriflunomide Product Overview
Table 64. Sanofi Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Cisen Pharmaceutical Basic Information
Table 69. Cisen Pharmaceutical Teriflunomide Product Overview
Table 70. Cisen Pharmaceutical Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Cisen Pharmaceutical Business Overview
Table 72. Cisen Pharmaceutical SWOT Analysis
Table 73. Cisen Pharmaceutical Recent Developments
Table 74. Nanjing Healthnice Pharmaceutical Basic Information
Table 75. Nanjing Healthnice Pharmaceutical Teriflunomide Product Overview
Table 76. Nanjing Healthnice Pharmaceutical Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Nanjing Healthnice Pharmaceutical Business Overview
Table 78. Nanjing Healthnice Pharmaceutical SWOT Analysis
Table 79. Nanjing Healthnice Pharmaceutical Recent Developments
Table 80. CGeneTech (Suzhou, China) Basic Information
Table 81. CGeneTech (Suzhou, China) Teriflunomide Product Overview
Table 82. CGeneTech (Suzhou, China) Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CGeneTech (Suzhou, China) Business Overview
Table 84. CGeneTech (Suzhou, China) Recent Developments
Table 85. Mylan Basic Information
Table 86. Mylan Teriflunomide Product Overview
Table 87. Mylan Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Mylan Business Overview
Table 89. Mylan Recent Developments
Table 90. Zydus Basic Information
Table 91. Zydus Teriflunomide Product Overview
Table 92. Zydus Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zydus Business Overview
Table 94. Zydus Recent Developments
Table 95. Accord Healthcare Basic Information
Table 96. Accord Healthcare Teriflunomide Product Overview
Table 97. Accord Healthcare Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Accord Healthcare Business Overview
Table 99. Accord Healthcare Recent Developments
Table 100. Dr. Reddy's Laboratories Basic Information
Table 101. Dr. Reddy's Laboratories Teriflunomide Product Overview
Table 102. Dr. Reddy's Laboratories Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Dr. Reddy's Laboratories Business Overview
Table 104. Dr. Reddy's Laboratories Recent Developments
Table 105. Glenmark Pharmaceuticals Basic Information
Table 106. Glenmark Pharmaceuticals Teriflunomide Product Overview
Table 107. Glenmark Pharmaceuticals Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Glenmark Pharmaceuticals Business Overview
Table 109. Glenmark Pharmaceuticals Recent Developments
Table 110. Teva Basic Information
Table 111. Teva Teriflunomide Product Overview
Table 112. Teva Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Teva Business Overview
Table 114. Teva Recent Developments
Table 115. Camber Pharmaceuticals Basic Information
Table 116. Camber Pharmaceuticals Teriflunomide Product Overview
Table 117. Camber Pharmaceuticals Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Camber Pharmaceuticals Business Overview
Table 119. Camber Pharmaceuticals Recent Developments
Table 120. Alembic Basic Information
Table 121. Alembic Teriflunomide Product Overview
Table 122. Alembic Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Alembic Business Overview
Table 124. Alembic Recent Developments
Table 125. Apotex Basic Information
Table 126. Apotex Teriflunomide Product Overview
Table 127. Apotex Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Apotex Business Overview
Table 129. Apotex Recent Developments
Table 130. Aurobindo Pharma Basic Information
Table 131. Aurobindo Pharma Teriflunomide Product Overview
Table 132. Aurobindo Pharma Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Aurobindo Pharma Business Overview
Table 134. Aurobindo Pharma Recent Developments
Table 135. SOLA Pharmaceuticals Basic Information
Table 136. SOLA Pharmaceuticals Teriflunomide Product Overview
Table 137. SOLA Pharmaceuticals Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. SOLA Pharmaceuticals Business Overview
Table 139. SOLA Pharmaceuticals Recent Developments
Table 140. Sandoz Basic Information
Table 141. Sandoz Teriflunomide Product Overview
Table 142. Sandoz Teriflunomide Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Sandoz Business Overview
Table 144. Sandoz Recent Developments
Table 145. Global Teriflunomide Sales Forecast by Region (2026-2035) & (K MT)
Table 146. Global Teriflunomide Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Teriflunomide Sales Forecast by Country (2026-2035) & (K MT)
Table 148. North America Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Teriflunomide Sales Forecast by Country (2026-2035) & (K MT)
Table 150. Europe Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Teriflunomide Sales Forecast by Region (2026-2035) & (K MT)
Table 152. Asia Pacific Teriflunomide Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Teriflunomide Sales Forecast by Country (2026-2035) & (K MT)
Table 154. South America Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Teriflunomide Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Teriflunomide Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Teriflunomide Sales Forecast by Type (2026-2035) & (K MT)
Table 158. Global Teriflunomide Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Teriflunomide Price Forecast by Type (2026-2035) & (USD/KG)
Table 160. Global Teriflunomide Sales (K MT) Forecast by Application (2026-2035)
Table 161. Global Teriflunomide Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Teriflunomide
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Teriflunomide Market Size (M USD), 2025-2035
Figure 5. Global Teriflunomide Market Size (M USD) (2020-2035)
Figure 6. Global Teriflunomide Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Teriflunomide Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Teriflunomide Product Life Cycle
Figure 13. Teriflunomide Sales Share by Manufacturers in 2025
Figure 14. Global Teriflunomide Revenue Share by Manufacturers in 2025
Figure 15. Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Teriflunomide Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Teriflunomide Revenue in 2025
Figure 18. Industry Chain Map of Teriflunomide
Figure 19. Global Teriflunomide Market PEST Analysis
Figure 20. Global Teriflunomide Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Teriflunomide Market Share by Type
Figure 27. Sales Market Share of Teriflunomide by Type (2020-2025)
Figure 28. Sales Market Share of Teriflunomide by Type in 2025
Figure 29. Market Share of Teriflunomide by Type (2020-2025)
Figure 30. Market Share of Teriflunomide by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Teriflunomide Market Share by Application
Figure 33. Global Teriflunomide Sales Market Share by Application (2020-2025)
Figure 34. Global Teriflunomide Sales Market Share by Application in 2025
Figure 35. Global Teriflunomide Market Share by Application (2020-2025)
Figure 36. Global Teriflunomide Market Share by Application in 2025
Figure 37. Global Teriflunomide Sales Growth Rate by Application (2020-2025)
Figure 38. Global Teriflunomide Sales Market Share by Region (2020-2025)
Figure 39. Global Teriflunomide Market Size by Region (2020-2025)
Figure 40. North America Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Teriflunomide Sales Market Share by Country in 2024
Figure 43. North America Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Teriflunomide Market Size by Country in 2024
Figure 45. U.S. Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Teriflunomide Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Teriflunomide Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Teriflunomide Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Teriflunomide Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Teriflunomide Sales Market Share by Country in 2024
Figure 53. Europe Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Teriflunomide Market Size by Country in 2024
Figure 55. Germany Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Teriflunomide Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Teriflunomide Sales Market Share by Region in 2024
Figure 67. Asia Pacific Teriflunomide Market Size by Region in 2024
Figure 68. China Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Teriflunomide Sales and Growth Rate (K MT)
Figure 79. South America Teriflunomide Sales Market Share by Country in 2024
Figure 80. South America Teriflunomide Market Size and Growth Rate (M USD)
Figure 81. South America Teriflunomide Market Size by Country in 2024
Figure 82. Brazil Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Teriflunomide Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Teriflunomide Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Teriflunomide Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Teriflunomide Market Size by Region in 2024
Figure 92. Saudi Arabia Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Teriflunomide Production Market Share by Region (2020-2025)
Figure 103. North America Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 106. China Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Teriflunomide Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Teriflunomide Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Teriflunomide Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Teriflunomide Market Share Forecast by Type (2026-2035)
Figure 111. Global Teriflunomide Sales Forecast by Application (2026-2035)
Figure 112. Global Teriflunomide Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Teriflunomide
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Teriflunomide Market Size (M USD), 2025-2035
Figure 5. Global Teriflunomide Market Size (M USD) (2020-2035)
Figure 6. Global Teriflunomide Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Teriflunomide Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Teriflunomide Product Life Cycle
Figure 13. Teriflunomide Sales Share by Manufacturers in 2025
Figure 14. Global Teriflunomide Revenue Share by Manufacturers in 2025
Figure 15. Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Teriflunomide Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Teriflunomide Revenue in 2025
Figure 18. Industry Chain Map of Teriflunomide
Figure 19. Global Teriflunomide Market PEST Analysis
Figure 20. Global Teriflunomide Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Teriflunomide Market Share by Type
Figure 27. Sales Market Share of Teriflunomide by Type (2020-2025)
Figure 28. Sales Market Share of Teriflunomide by Type in 2025
Figure 29. Market Share of Teriflunomide by Type (2020-2025)
Figure 30. Market Share of Teriflunomide by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Teriflunomide Market Share by Application
Figure 33. Global Teriflunomide Sales Market Share by Application (2020-2025)
Figure 34. Global Teriflunomide Sales Market Share by Application in 2025
Figure 35. Global Teriflunomide Market Share by Application (2020-2025)
Figure 36. Global Teriflunomide Market Share by Application in 2025
Figure 37. Global Teriflunomide Sales Growth Rate by Application (2020-2025)
Figure 38. Global Teriflunomide Sales Market Share by Region (2020-2025)
Figure 39. Global Teriflunomide Market Size by Region (2020-2025)
Figure 40. North America Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Teriflunomide Sales Market Share by Country in 2024
Figure 43. North America Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Teriflunomide Market Size by Country in 2024
Figure 45. U.S. Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Teriflunomide Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Teriflunomide Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Teriflunomide Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Teriflunomide Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Teriflunomide Sales Market Share by Country in 2024
Figure 53. Europe Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Teriflunomide Market Size by Country in 2024
Figure 55. Germany Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Teriflunomide Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Teriflunomide Sales Market Share by Region in 2024
Figure 67. Asia Pacific Teriflunomide Market Size by Region in 2024
Figure 68. China Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Teriflunomide Sales and Growth Rate (K MT)
Figure 79. South America Teriflunomide Sales Market Share by Country in 2024
Figure 80. South America Teriflunomide Market Size and Growth Rate (M USD)
Figure 81. South America Teriflunomide Market Size by Country in 2024
Figure 82. Brazil Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Teriflunomide Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Teriflunomide Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Teriflunomide Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Teriflunomide Market Size by Region in 2024
Figure 92. Saudi Arabia Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Teriflunomide Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Teriflunomide Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Teriflunomide Production Market Share by Region (2020-2025)
Figure 103. North America Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 106. China Teriflunomide Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Teriflunomide Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Teriflunomide Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Teriflunomide Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Teriflunomide Market Share Forecast by Type (2026-2035)
Figure 111. Global Teriflunomide Sales Forecast by Application (2026-2035)
Figure 112. Global Teriflunomide Market Share Forecast by Application (2026-2035)
